News
T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...
3d
News-Medical.Net on MSNInterferon regulatory factor 8 identified as key driver of liver fat buildup in NAFLDNon-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.
Brain tissue analysis of an animal model has revealed the potential role of immune system dysfunction in the onset and ...
Interferon regulatory factor 8 (IRF8) is well known for its roles in immune cell differentiation and tumor pathogenesis; however, its role in regulating glucose homeostasis and lipid metabolism ...
4d
News-Medical.Net on MSNVitamin D curbs colorectal cancer by boosting immunity and blocking tumor growthReview highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...
The following is a summary of āA gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland,ā published in the April ...
Team identifies key regulator blocking immunotherapy, paving the way for a new lung cancer treatment
Immune checkpoint inhibitors ... showed that combination therapy targeting DDX54 promoted the differentiation of T cells and memory T cells that suppress tumors, while reducing the infiltration ...
This study uncovers dynamic immune adaptations during pregnancy through single-cell RNA sequencing of peripheral blood ...
Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results